Prevention of contrast-induced nephropathy with ascorbic acid

Internal Medicine

Volumn 51, Issue 6, 2012, Pages 531-535

  Zhou, Li ^a   Chen, Hui ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Angiography; Ascorbic acid; Contrast medium; Nephropathy

Indexed keywords

ASCORBIC ACID; CREATININE; PLACEBO;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHRONIC KIDNEY FAILURE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG MEGADOSE; FEMALE; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; HYDRATION; KIDNEY FUNCTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ACUTE KIDNEY INJURY; ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; ASCORBIC ACID; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; FEMALE; FLUID THERAPY; HEART CATHETERIZATION; HUMANS; INJECTIONS, INTRAVENOUS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREMEDICATION; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT FAILURE;

EID: 84863229286     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.6260     Document Type: Article

References (14)

1. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 39: 930-936, 2002.
2. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105: 2259-2264, 2002.
3. Barrett BJ, Parfrey PS. Clinical practice: Preventing nephropathy induced by contrast medium. N Engl J Med 354: 379-386, 2006.
4. McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol 51: 1419-1428, 2008.
5. Berg KJ. Nephrotoxicity related to contrast media. Scand J Urol Nephrol 34: 317-322, 2000.
6. Morcos SK, Thomsen HS, Webb JA. Contrast-media-induced nephrotoxicity: a consensus report. Eur Radiol 9: 1602-1613, 1999.
7. Waybill MM, Waybill PN. Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention. J Vasc Interv Radiol 12: 3-9, 2001.
8. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39: S1-S266, 2002.
9. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic contrast agent induced reductions in renal function by acetylcysteine. N Engl J Med 343: 180-184, 2000.
10. Fishbane S, Durham JH, Marzo K, Rudnick M. N-Acetylcysteine in the prevention of radiocontrast-induced nephropathy. J Am Soc Nephrol 15: 251-260, 2004.
11. Lloberas N, Torras J, Herrero-Fresnada I, et al. Postischemic renal oxidative stress induces inflammatory response through PAF and oxidized phospholipids: prevention by antioxidant treatment. FASEB J 16: 908-910, 2002.
12. Durak I, Ozbek H, Karaayvaz M, Ozturk HS. Cisplatin induces acute renal failure by impairing antioxidant system in guinea pig: effects of antioxidant supplementation on the cisplatin nephrotoxicity. Drug Chem Toxico 25: 1-8, 2002.
13. Ali BH. Agents ameliorating or augmenting experimental gentamicin nephrotoxicity: some recent research. Food Chem Toxicol 41: 1447-1452, 2003.
14. Spargias K, Alexopoulos E, Kyrzopoulos S. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 110: 2837-2842, 2004.